Luna FX7 automated cell counter for CAR-T cell therapey development

Chimeric antigen receptor (CAR) T cell therapy represents a major advance toward providing personalized cancer treatment. Unlike chemotherapy that can affect both healthy and cancerous cells, CAR-T cell therapy specifically targets tumor cells for destruction by the patient’s own immune system. Producing effective CAR-T cell therapies requires that cell number and viability be closely monitored throughout the entire development and biomanufacturing process. The LUNA-FX7™ provides the high level of accuracy required to meet strict quality and regulatory guidelines, making it an ideal cell counter for CAR-T cell therapy research.
https://www.biocompare.com/3464-Tech-Insights/573608-Accurately-Monitor-Cell-Health-During-CAR-T-Cell-Therapy-Production-with-the-LUNA-FX7/